Yaohai Bio-Pharma to Showcase End-to-End Microbial CRDMO Solutions at BIO International Convention 2026 in San Diego
Yaohai Bio-Pharma will attend the upcoming BIO International Convention 2026 (BIO US 2026), the global biopharmaceutical industry’s largest and most comprehensive gathering. The convention will take place from June 22–25, 2026, at the San Diego Convention Center in San Diego, California. Global biopharma partners and attendees are invited to connect with the Yaohai team at Booth 3943, located within the China Pavilion.
At the event, Yaohai Bio-Pharma will present its comprehensive, end-to-end microbial CRDMO solutions, engineered to accelerate biopharmaceutical development from early-stage research through to commercial GMP production.
Showcasing End-to-End Microbial CRDMO Capabilities
At BIO US 2026, Yaohai Bio-Pharma will highlight its integrated microbial CRDMO platform, designed to support therapeutic pipelines across their full lifecycle. By offering seamless services that optimize speed, scalability, and cost efficiency, Yaohai enables biotech and pharmaceutical innovators to advance their programs with enhanced flexibility and confidence.
Key capabilities featured at the convention include:
Recombinant Proteins & Peptides
mRNA
Nano-bodies
Plasmid DNA
Innovative Vaccines
Leveraging advanced microbial expression systems, Yaohai delivers high-yield, reliable manufacturing solutions that are vital for modern biologics production, particularly where rapid timelines and cost-efficiency are critical.
Connect with Yaohai Bio-Pharma at the China Pavilion
By exhibiting at Booth 3943 (China Pavilion), Yaohai Bio-Pharma aims to deepen its global partnerships and expand its collaborative footprint within the international biotech ecosystem. Visitors to the booth will have the opportunity to:
Meet with Experts: Engage directly with Yaohai’s scientific and business development leaders.
Explore Customized Solutions: Discover tailored CRDMO frameworks built to optimize specific project workflows.
Foster Strategic Collaboration: Identify long-term alignment to accelerate global market entry.
Yaohai welcomes both existing partners and new contacts to schedule one-on-one partnering meetings during the convention to explore how its robust microbial platforms can shorten development timelines.
About BIO International Convention
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. Hosted by the Biotechnology Innovation Organization (BIO), the event features extensive partnering opportunities, specialized education sessions, and a massive exhibition floor, fostering international collaboration and driving innovation across the global healthcare value chain.
About Yaohai Bio-Pharma
Yaohai Bio-Pharma is a premier CRDMO with extensive expertise in microbial expression systems. The company focuses on recombinant proteins, mRNA, nano-bodies, plasmid DNA, and innovative vaccines, offering full-lifecycle solutions from R&D to commercial manufacturing. Yaohai is dedicated to building an open, integrated CRO/CDMO/MAH platform that empowers global partners to transition smoothly from discovery to market.
